Safety of bevacizumab plus chemotherapy as first-line treatment of patients with metastatic colorectal cancer: Updated results from a large observational registry in the US (BRiTE).

被引：0
|
作者：
Hedrick, E.
Kozloff, M.
Hainsworth, J.
Badarinath, S.
Cohn, A.
Flynn, P.
Dong, W.
Suzuki, S.
Sugrue, M.
Grothey, A.
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Univ Chicago, Chicago, IL 60637 USA
[3] Sarah Cannon Res Inst, Nashville, TN USA
[4] Florida Oncol Associates, Jacksonville, FL USA
[5] Rocky Mt Canc Ctr, Denver, CO USA
[6] Abbott NW Hosp, Minneapolis, MN 55407 USA
[7] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3536
引用
收藏
页码：155S / 155S
页数：1
相关论文
共 50 条
  • [41] Bevacizumabplus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: Results from a large German community-based observational cohort study
    Stein, Alexander
    Petersen, Volker
    Schulze, Mathias
    Seraphin, Joerg
    Hoeffkes, Heinz-Gert
    Valdix, Anette R.
    Schroeder, Jan
    Herrenberger, Julia
    Boxberger, Frank
    Leutgeb, Barbara
    Hinke, Axel
    Kutscheidt, Andreas
    Arnold, Dirk
    ACTA ONCOLOGICA, 2015, 54 (02) : 171 - 178
  • [42] First-line treatment with bevacizumab plus capecitabine for elderly patients with metastatic colorectal cancer: BECA trial
    Feliu, J.
    Salut, A.
    Safont, M.
    Losa, F.
    Garcia, C.
    Bosch, C.
    Escudero, P.
    Lopez, R.
    Bolanos, M.
    Gonzalez-Baron, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] FOLFOXIRI plus bevacizumab as first-line treatment of BRAF-mutant metastatic colorectal cancer patients
    Salvatore, Lisa
    Loupakis, Fotios
    Cremolini, Chiara
    Schirripa, Marta
    Masi, Gianluca
    Antoniotti, Carlotta
    Fornaro, Lorenzo
    Sensi, Elisa
    Lupi, Cristiana
    Bergamo, Francesca
    Lonardi, Sara
    Zagonel, Vittorina
    Fontanini, Gabriella
    Falcone, Alfredo
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] Combination of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: Slovakian experience
    Salek, T.
    Mego, M.
    Mardiak, J.
    Andrasina, I.
    Spanik, S.
    Malec, V.
    Barilla, R.
    Riedelova, K.
    Benedikty, A.
    Dammak, A.
    Porsok, S.
    Svabova, V.
    Chovanec, M.
    Cipkova, A.
    Usakova, V.
    Siskova, M.
    Jurisova, S.
    Dolinsky, J.
    Hlavata, Z.
    Andrezalova, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] Clinical Outcomes in Elderly Patients with Metastatic Colorectal Cancer Receiving Bevacizumab and Chemotherapy: Results from the BRiTE Observational Cohort Study
    Kozloff, Mark F.
    Berlin, Jordan
    Flynn, Patrick J.
    Kabbinavar, Fairooz
    Ashby, Mark
    Dong, Wei
    Sing, Amy P.
    Grothey, Axel
    ONCOLOGY, 2010, 78 (5-6) : 329 - 339
  • [46] Bevacizumab in combination with chemotherapy in the first-line treatment of metastatic colorectal carcinoma
    Usakova, V.
    Sevcikova, K.
    Usak, J.
    Bartosova, Z.
    Mikulova, M.
    Spanik, S.
    NEOPLASMA, 2013, 60 (01) : 83 - 91
  • [47] Safety and effectiveness of bevacizumab (BV) and chemotherapy (CT) in elderly patients (pts) with metastatic colorectal cancer (mCRC): Results from the BRiTE observational cohort study
    Kozloff, M. F.
    Sugrue, M. M.
    Purdie, D. M.
    Berlin, J. D.
    Flynn, P. J.
    Kabbinavar, F. F.
    Sargent, D. J.
    Dong, W.
    Grothey, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] Effect of bevacizumab combined with first-line chemotherapy on metastatic colorectal cancer
    Xiong, Lifeng
    Lou, Yinmei
    Wang, Lin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (04): : 3609 - 3617
  • [49] Safety and effectiveness of bevacizumab (BV) plus chemotherapy (CT) in elderly patients with mCRC: results from the BRiTE registry
    Sugrue, M.
    Kozloff, M.
    Hainsworth, J.
    Badarinath, S.
    Cohn, A.
    Flynn, P.
    Dong, W.
    Purdie, D.
    Yi, J.
    Grothey, A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 250 - 250
  • [50] Bevacizumab plus chemotherapy as first-line therapy for elderly patients with metastatic colorectal cancer: Interim results of the noninterventional CASSIOPEE study.
    Francois, Eric
    Kim, Stefano Chong Hun
    Burki, Franck
    Laplaige, Philippe
    Smith, Denis Michel
    Gourgou, Sophie
    Rollot, Florence
    Barue, Vanessa
    Gandon, Sophie
    Mineur, Laurent
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345